Education
About Us
Working with TipRanks
Follow Us
Rennova Health (RNVA)
OTHER OTC:RNVA
Total Valuation
Rennova Health has a market cap or net worth of $4.31M. The enterprise value is $14.84M.
Market Cap$4.31M
Enterprise Value$14.84M
Share Statistics
Rennova Health has 43,051,320,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding43,051,320,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rennova Health’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is -12.76%.
Return on Equity (ROE)0.21
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-12.76%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee194.64K
Profits Per Employee-5.77K
Employee Count96
Asset Turnover0.92
Inventory Turnover38.23
Valuation Ratios
The current PE Ratio of Rennova Health is -0.42. Rennova Health’s PEG ratio is <0.01.
PE Ratio-0.42
PS Ratio0.00
PB Ratio>-0.01
Price to Fair Value-0.09
Price to FCF-0.04
Price to Operating Cash Flow-0.05
PEG Ratio<0.01
Income Statement
In the last 12 months, Rennova Health had revenue of 18.69M and earned -7.73M in profits. Earnings per share was 0.00.
Revenue18.69M
Gross Profit11.11M
Operating Income1.37M
Pretax Income-314.04K
Net Income-7.73M
EBITDA1.45M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 3.39M and capital expenditures -350.93K, giving a free cash flow of 3.04M billion.
Operating Cash Flow3.39M
Free Cash Flow3.04M
Free Cash Flow per Share<0.01
Dividends & Yields
Rennova Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-36.46
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Rennova Health upcoming earnings date is Apr 23, 2018, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateApr 23, 2018
Ex-Dividend Date―
Financial Position
Rennova Health as a current ratio of 0.16, with Debt / Equity ratio of -52.69%
Current Ratio0.16
Quick Ratio0.16
Debt to Market Cap3.48
Net Debt to EBITDA8.09
Interest Coverage Ratio0.94
Taxes
In the past 12 months, Rennova Health has paid 239.83K in taxes.
Income Tax239.83K
Effective Tax Rate-0.76
Enterprise Valuation
Rennova Health EV to EBITDA ratio is 10.36, with an EV/FCF ratio of 4.94.
EV to Sales0.80
EV to EBITDA10.36
EV to Free Cash Flow4.94
EV to Operating Cash Flow4.43
Balance Sheet
Rennova Health has $49.02K in cash and marketable securities with $11.78M in debt, giving a net cash position of $11.73M billion.
Cash & Marketable Securities$49.02K
Total Debt$11.78M
Net Cash$11.73M
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 48.08%, with operating margin of 7.31%, and net profit margin of -41.36%.
Gross Margin48.08%
Operating Margin7.31%
Pretax Margin-1.68%
Net Profit Margin-41.36%
EBITDA Margin7.76%
EBIT Margin6.09%
Analyst Forecast
The average price target for Rennova Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―